Latest news
Silence Therapeutics Jumps Over 25% After Divesiran Phase 2 Trial Supports 12-Week Dosing - TechStock²TechStock² · Mon, 10 Aug 2026 20:28:54 GMTQuanterix (NASDAQ:QTRX) Drops 39% After Outlook Revision Pushes Breakeven Back to 2027 - TechStock²TechStock² · Mon, 10 Aug 2026 17:07:50 GMTDow Jones: Four stocks drive 178-point swing in live session - TechStock²TechStock² · Mon, 10 Aug 2026 16:53:23 GMTMark Cuban Says AI Will Reduce Misinformation, Pushes Back Against Warnings That Users Will Blindly Trust - BenzingaBenzinga · Fri, 07 Aug 2026 06:49:38 GMTWing Yip Food (NASDAQ:WYHG; KOSDAQ:900340) jumps 582% as U.S. ADSs detach from Korean shares - TechStock²TechStock² · Thu, 06 Aug 2026 18:00:39 GMT